Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
Osteopenia and osteoporosis are being described more frequently in people with HIV infection.
This study will test the efficacy of alendronate in comparison with a placebo after 2 years,
in people with primary osteoporosis. People will receive the recommended adequate intake of
calcium and vitamin D.
Phase:
Phase 3
Details
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis